Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sokka

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|September 24, 1999
Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 yearsT Sokka, P Hannonen
Annals of the Rheumatic Diseases|July 27, 2000
Healing of erosions in rheumatoid arthritisT Sokka, P Hannonen
Clinical and Experimental Rheumatology|November 9, 2005
Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical careT Pincus, T Sokka
Rheumatology (Oxford, England)|August 9, 2008
Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United StatesT Sokka, T Pincus
Clinical and Experimental Rheumatology|December 17, 2008
Should an order to "monitor long-term vital signs," including mortality outcomes, be as routine as an order for a laboratory test in patients with rheumatic diseases?T Pincus, T Sokka
Clinical and Experimental Rheumatology|November 4, 2010
Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patientsT Pincus, V Furer, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapiesT Pincus, A Kavanaugh, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard careT Pincus, T Sokka, A Kavanaugh
Rheumatology (Oxford, England)|February 9, 2000
Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literatureT Sokka, T Möttönen, P Hannonen
Arthritis and Rheumatism|February 29, 2000
Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scoresT Sokka, A Kankainen, P Hannonen
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|September 24, 1999
Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 yearsT Sokka, P Hannonen
Annals of the Rheumatic Diseases|July 27, 2000
Healing of erosions in rheumatoid arthritisT Sokka, P Hannonen
Clinical and Experimental Rheumatology|November 9, 2005
Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical careT Pincus, T Sokka
Rheumatology (Oxford, England)|August 9, 2008
Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United StatesT Sokka, T Pincus
Clinical and Experimental Rheumatology|December 17, 2008
Should an order to "monitor long-term vital signs," including mortality outcomes, be as routine as an order for a laboratory test in patients with rheumatic diseases?T Pincus, T Sokka
Clinical and Experimental Rheumatology|November 4, 2010
Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patientsT Pincus, V Furer, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapiesT Pincus, A Kavanaugh, T Sokka
Clinical and Experimental Rheumatology|November 24, 2004
Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard careT Pincus, T Sokka, A Kavanaugh
Rheumatology (Oxford, England)|February 9, 2000
Disease-modifying anti-rheumatic drug use according to the 'sawtooth' treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literatureT Sokka, T Möttönen, P Hannonen
Arthritis and Rheumatism|February 29, 2000
Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scoresT Sokka, A Kankainen, P Hannonen
Pageof 9